Patents by Inventor Josee Hamel

Josee Hamel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • () polypeptides and corresponding DNA fragments
    Patent number: 7329500
    Abstract: The present invention relates to polypeptides of Moraxella (Branhamela) catarrhalis which may be used for prophy-laxis, diagnostic and/or therapy purposes.
    Type: Grant
    Filed: August 27, 2002
    Date of Patent: February 12, 2008
    Assignee: ID Biomedical Corporation
    Inventors: Denis Martin, Josée Hamel, Bernard R. Brodeur, Stéphane Rioux, Julie Couture
  • Group b streptococcus antigens
    Publication number: 20070275004
    Abstract: The present invention relates to polypeptides, epitopes and antibodies directed to these epitopes, more particularly to the Sip polypeptide of Group B streptococcus (GBS), also called Streptococcus Agalactiae which may be used to prevent, diagnose and/or treat streptococcal infection.
    Type: Application
    Filed: February 11, 2003
    Publication date: November 29, 2007
    Inventors: Stephane Rioux, Denis Martin, Josee Hamel, Bernard Brodeur
  • Proteinase K resistant surface protein of neisseria meningitidis
    Patent number: 7273611
    Abstract: The identification of a highly conserved, immunologically accessible antigen on the surface of Neisseria facilitates treatment, prophylaxis, and diagnosis of Neisseria diseases. This antigen is highly resistant to proteinase K and has an apparent molecular weight of 22 kDa on SDS-PAGE. Specific polynucleotides encoding proteins of this class have been isolated from three Neisseria meningitidis strains and from one Neisseria gonorrhoaea strain. These polynucleotides have been sequenced, and the corresponding full-length amino acid sequences of the encoded polypeptides have been deduced. Recombinant DNA methods for the production of the Neisseria surface protein, and antibodies that bind to this protein are also disclosed.
    Type: Grant
    Filed: October 6, 2000
    Date of Patent: September 25, 2007
    Assignee: ID Biomedical Corporation
    Inventors: Bernard R. Brodeur, Denis Martin, Josee Hamel, Clement Rioux
  • antigens
    Patent number: 7262024
    Abstract: The present invention relates to polypeptides of Streptococcus pneumoniae which may be used for prophylaxis, diagnostic and/or therapy purposes.
    Type: Grant
    Filed: December 20, 2002
    Date of Patent: August 28, 2007
    Assignee: ID Biomedical Corporation
    Inventors: Josée Hamel, Nathalie Charland, Bernard R. Brodeur, Denis Martin, Normand Blais, Catherine Ouellet, Steve Labbe
  • antigens
    Patent number: 7247308
    Abstract: The present invention relates to antigens, more particularly an antigen of Streptococcus pygenes (also called group A Streptococcus (GAS)) bacterial pathogen which is useful as vaccine component for therapy and/or prophylaxis.
    Type: Grant
    Filed: July 6, 2001
    Date of Patent: July 24, 2007
    Assignee: ID Biomedical Corporation
    Inventors: Denis Martin, Josee Hamel, Bernard Brodeur, Stephane Rioux, Martine Boyer
  • Novel streptococcus antigens
    Publication number: 20070116712
    Abstract: Streptococcus proteins and polynucleotides encoding them are disclosed. Said proteins are antigenic and therefore useful vaccine components for the prophylaxis or therapy of streptococcus infection in animals. Also disclosed are recombinant methods of producing the protein antigens as well as diagnostic assays for detecting streptococcus bacterial infection.
    Type: Application
    Filed: August 29, 2006
    Publication date: May 24, 2007
    Applicant: ID Biomedical Corporation
    Inventors: Josee Hamel, Bernard Brodeur, Isabelle Pineau, Denis Martin, Clement Rioux, Nathalie Charland
  • Polypeptides of streptococcus pyogenes
    Publication number: 20070110763
    Abstract: The present invention relates to polypeptides of S. pyogenes which may be useful to prevent, diagnose and/or treat S. pyogenes infections.
    Type: Application
    Filed: August 16, 2004
    Publication date: May 17, 2007
    Inventors: Stephane Rioux, Denis Martin, Josee Hamel, Bernard Brodeur, Patrick Rheault, Nathalie Drouin
  • Proteinase K resistant surface protein of neisseria meningitidis
    Publication number: 20070110766
    Abstract: The identification of a highly conserved, immunologically accessible antigen at the surface of Neisseria facilitates treatment, prophylaxis, and diagnosis of Neisseria diseases. This antigen is highly resistant to Proteinase K and has an apparent molecular weight of 22 kDa on SDS-PAGE. Specific polynucleotides encoding proteins of this class have been isolated from three Neisseria meningitidis strains and from one Neisseria gonorrhoeae strain. These polynucleotides have been sequenced, and the corresponding full-length amino acid sequences of the encoded polypeptides have been deduced. Recombinant DNA methods for the production of the Neisseria surface protein, and antibodies that bind to this protein are also disclosed.
    Type: Application
    Filed: October 16, 2006
    Publication date: May 17, 2007
    Applicant: ID Biomedical Corporation
    Inventors: Bernard Brodeur, Denis Martin, Josee Hamel, Clement Rioux
  • antigens
    Patent number: 7128918
    Abstract: Streptococcus proteins and polynucleotides encoding them are disclosed. Said proteins are antigenic and therefore useful vaccine components for the prophylaxis or therapy of streptococcus infection in animals. Also disclosed are recombinant methods of producing the protein antigens as well as diagnostic assays for detecting streptococcus bacterial infection.
    Type: Grant
    Filed: December 23, 1999
    Date of Patent: October 31, 2006
    Assignee: ID Biomedical Corporation
    Inventors: Josee Hamel, Bernard R. Brodeur, Isabelle Pineau, Denis Martin, Clement Rioux, Nathalie Charland
  • Streptococcus antigens
    Publication number: 20060177465
    Abstract: Streptococcus polypeptides and polynucleotides encoding them are disclosed. Said polypeptides may be useful vaccine components for the prophylaxis or therapy of streptococcus infection in animals. Also disclosed are recombinant methods of producing the protein antigens as well as diagnostic assays for detecting streptococcus bacterial infection.
    Type: Application
    Filed: January 25, 2006
    Publication date: August 10, 2006
    Applicant: ID Biomedical
    Inventors: Josee Hamel, Catherine Ouellet, Nathalie Charland, Denis Martin, Bernard Brodeur
  • Streptococcus antigens
    Patent number: 7074415
    Abstract: Streptococcus polypeptides and polynucleotides encoding them are disclosed. The polypeptides may be useful vaccine components for the prophylaxis or therapy of streptococcus infection in animals. Also disclosed are recombinant methods of producing the protein antigens as well as diagnostic assays for detecting streptococcus bacterial infection.
    Type: Grant
    Filed: June 20, 2001
    Date of Patent: July 11, 2006
    Assignee: ID Biomedical Corporation
    Inventors: Josée Hamel, Catherine Ouellet, Nathalie Charland, Denis Martin, Bernard Brodeur
  • Polypeptides of pseudomonas aeruginosa
    Publication number: 20050107597
    Abstract: The present invention relates to polypeptides of Pseudomonas aeruginosa which may be used to prevent, diagnose and/or treat Pseudomonas aeruginosa infection.
    Type: Application
    Filed: November 13, 2002
    Publication date: May 19, 2005
    Inventors: Nathalie Charland, Josee Hamel, Bernard Brodeur, Denis Martin, Isabelle Charlebois, Diane Bussiere
  • Moraxella (branhamella) catarrhalis antigens
    Publication number: 20050080233
    Abstract: The present invention relates to polypeptides of Moraxella (Branhamella) catarrhalis which may be useful for prophylaxis, diagnostic and/or therapy purposes.
    Type: Application
    Filed: June 18, 2002
    Publication date: April 14, 2005
    Inventors: Denis Martin, Josee Hamel, Bernard Brodeur, Stephane Rioux, Genevieve Leblanc, Julie Couture
  • Polypeptides of moraxella (branhamella) catarrhalis
    Publication number: 20050070691
    Abstract: The present invention relates to polypeptides, more particularly polypeptides of Moraxella (Branhamella) catarrhalis which may be used to prevent, diagnose and/or treat Moraxella (Branhamella) catarrhalis infection.
    Type: Application
    Filed: November 15, 2002
    Publication date: March 31, 2005
    Inventors: Denis Martin, Josee Hamel, Bernard Brodeur, Stephane Rioux, Julie Couture
  • Group b streptococcus antigens and corresponding dna fragments
    Publication number: 20040242844
    Abstract: The present invention relates to antigens, more particularly antigens of Group B Streptococcus (GBS) (S. agalactiae) which may be useful to prevent, diagnose and/or treat streptococcal infections.
    Type: Application
    Filed: July 16, 2004
    Publication date: December 2, 2004
    Inventors: Denis Martin, Stephane Rioux, Bernard Brodeur, Josee Hamel, Martine Boyer
  • Moraxella (branhamella) catarrhalis polypeptides and corresponding dna fragments
    Publication number: 20040242859
    Abstract: The present invention relates to polypeptides of Moraxella (Branhamela) catarrhalis wich may be used for prophy-laxis, diagnostic and/or therapy purposes.
    Type: Application
    Filed: February 26, 2004
    Publication date: December 2, 2004
    Inventors: Denis Martin, Josee Hamel, Bernard Brodeur, Stephane Rioux, Julie Couture
  • Moraxella(branhamella) catarrhalis antigens
    Publication number: 20040236087
    Abstract: The present invention relates to polypeptides of Moraxella(Branhamella) calarrhalis which may be useful for prophylaxis, diagnosis and/or therapy purposes.
    Type: Application
    Filed: June 2, 2004
    Publication date: November 25, 2004
    Inventors: Denis Martin, Josee Hamel, Bernard R. Brodeur, Stephane Rioux, Julie Couture
  • Haemophilus influenzae antigens and corresponding dna fragments
    Publication number: 20040171802
    Abstract: The present invention relates to polypeptides of Haemophilus influenzae which may be used for prophylaxis, diagnostic and/or therapy purposes.
    Type: Application
    Filed: April 2, 2003
    Publication date: September 2, 2004
    Inventors: Josee Hamel, France Couture, Bernard R. Brodeur, Denis Martin, Catherine Quellet, Mireille Tremblay, Annie Charbonneau, Catherine Vayssier
  • Antigens of group b streptococcus and corresponding dna fragments
    Publication number: 20040171113
    Abstract: The present invention relates to antigens, more particularly antigens of Group B Streptococcus (GBS) (S. agalactiae) which may be useful to prevent, diagnose and/or treat streptococcal infections.
    Type: Application
    Filed: April 19, 2004
    Publication date: September 2, 2004
    Inventors: Denis Martin, Josee Hamel, Bernard R Brodeur, Stephane Rioux, Martine Boyer
  • Streptococcus pyogenes antigens and corresponding dna fragments
    Publication number: 20040097706
    Abstract: The present invention relates to antigens, more particularly antigens of Streptococcus pyogenes (also called group A Streptococcus (GAS)) bacterial pathogen which are useful as vaccine component for therapy and/or prophylaxis.
    Type: Application
    Filed: November 18, 2003
    Publication date: May 20, 2004
    Inventors: Denis Martin, Bernard Brodeur, Josee Hamel, Stephane Rioux, Patrick Rheault